文献速递胃肠外科围术期管理与 ERAS

多模式预康复对腹部癌症手术围术期免疫功能的影响

Multimodal prehabilitation and perioperative immune function in patients undergoing abdominal cancer surgery.
PubMed 文献 · Br J Surg · 2026-01-01

本研究基于F4S PREHAB试验子组,纳入130例择期腹部癌症手术患者(预康复组102例,对照组28例),评估多模式预康复对围术期免疫功能的影响。结果显示预康复后促炎细胞因子体外产生减少、抗炎白细胞介素10(IL-10)产生增加,血浆白细胞介素6(IL-6)和IL-10浓度降低;但术后第1天(POD1)两组免疫功能无显著差异。结论提示预康复可能影响基础免疫功能、使炎症状态减轻,但对术后免疫功能的影响可能有限。

要点

  • 多模式预康复可降低术前促炎细胞因子体外产生并升高抗炎IL-10产生。
  • 预康复后血浆IL-6和IL-10浓度较对照降低。
  • 术后第1天预康复组与对照组免疫功能无显著差异。

核心结论

  • 多模式预康复影响基础免疫功能,使机体呈现较轻的炎症状态,但对术后第1天免疫功能的影响可能有限。

主要发现

  • 预康复后促炎细胞因子体外产生减少,抗炎细胞因子白细胞介素10(IL-10)体外产生增加。
  • 预康复后血浆白细胞介素6(IL-6)和IL-10浓度降低。
  • 术后第1天(POD1)预康复组与对照组术后免疫功能无显著差异。

临床怎么用

  • 预康复可能通过调节基础免疫状态使术前炎症水平降低,但不应期望其显著改善术后第1天免疫功能。

局限性

  • 本研究为探索性亚组分析,对照组样本量较小(28例),可能影响统计效能。
  • 免疫功能评估仅至术后第1天,无法反映更后期变化。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Prehabilitation is an emerging preoperative strategy designed to optimize patients' functional capacity before surgery to improve postoperative outcomes. Previous studies have demonstrated its clinical benefit, including enhanced recovery and reduced postoperative complications. However, the mechanisms underlying these benefits remain poorly understood. The aim of this exploratory study was to investigate the potential effects of prehabilitation on preoperative and postoperative immune function. METHODS: This prospective study utilized data and material from a subgroup of patients participating in the F4S PREHAB trial (NL73777.091.20), which is a stepped-wedge trial investigating the effects of multimodal prehabilitation before major surgery. In this substudy, patients who underwent elective bladder, oesophageal, or rectal cancer surgery between June 2022 and November 2023 were included. Immune function was assessed at baseline, after the prehabilitation or usual care interval, and on postoperative day 1 (POD1) by examining ex vivo cytokine production capacity, plasma cytokine concentrations, and monocytic human leucocyte antigen DR (mHLA-DR) expression. RESULTS: This substudy included 130 patients: 102 in the prehabilitation group and 28 in the control group. After prehabilitation, the ex vivo production of pro-inflammatory cytokines was reduced, whereas the ex vivo production of the anti-inflammatory cytokine interleukin 10 (IL-10) was increased. Plasma concentrations of interleukin 6 (IL-6) and IL-10 were lower after prehabilitation. On POD1, no significant differences in postoperative immune function were observed between the prehabilitation and control groups. CONCLUSION: This study suggests that multimodal prehabilitation influences basal immune function, leading to a less inflammatory state. However, as no significant differences in immune function were observed between the prehabilitation and control groups on POD1, the impact of prehabilitation on postoperative immune function may be limited.

来源:Br J Surg,查看原文。版权归原作者所有。

引用

  1. Jacobs LMC, Drager LD, van Eijk LT, et al. Multimodal prehabilitation and perioperative immune function in patients undergoing abdominal cancer surgery. Br J Surg. 2026. PMID: 42250247. doi:10.1093/bjs/znag070

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。